Nj State Employees Deferred Compensation Plan Zai Lab LTD Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Zai Lab LTD stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 11,300 shares of ZLAB stock, worth $391,997. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,300
Previous 11,300
-0.0%
Holding current value
$391,997
Previous $272,000
8.46%
% of portfolio
0.04%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding ZLAB
# of Institutions
146Shares Held
53MCall Options Held
103KPut Options Held
439K-
Wellington Management Group LLP Boston, MA6.66MShares$231 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.57MShares$228 Million0.09% of portfolio
-
Capital World Investors Los Angeles, CA6.43MShares$223 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.17MShares$110 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$87 Million1.07% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.4B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...